320 related articles for article (PubMed ID: 25538250)
1. Osteoblast menin regulates bone mass in vivo.
Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
[TBL] [Abstract][Full Text] [Related]
2. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
3. Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD.
Naito J; Kaji H; Sowa H; Hendy GN; Sugimoto T; Chihara K
J Biol Chem; 2005 Feb; 280(6):4785-91. PubMed ID: 15563473
[TBL] [Abstract][Full Text] [Related]
4. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
5. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
[TBL] [Abstract][Full Text] [Related]
7. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis.
Moriishi T; Maruyama Z; Fukuyama R; Ito M; Miyazaki T; Kitaura H; Ohnishi H; Furuichi T; Kawai Y; Masuyama R; Komori H; Takada K; Kawaguchi H; Komori T
PLoS One; 2011; 6(11):e27487. PubMed ID: 22114675
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage.
Sowa H; Kaji H; Canaff L; Hendy GN; Tsukamoto T; Yamaguchi T; Miyazono K; Sugimoto T; Chihara K
J Biol Chem; 2003 Jun; 278(23):21058-69. PubMed ID: 12649288
[TBL] [Abstract][Full Text] [Related]
10. Role of menin in bone development.
Kaji H; Canaff L; Hendy GN
Adv Exp Med Biol; 2009; 668():59-67. PubMed ID: 20175453
[TBL] [Abstract][Full Text] [Related]
11. Menin and bone metabolism.
Kaji H
J Bone Miner Metab; 2012 Jul; 30(4):381-7. PubMed ID: 22543820
[TBL] [Abstract][Full Text] [Related]
12. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
[TBL] [Abstract][Full Text] [Related]
13. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice.
Yan Y; Tang D; Chen M; Huang J; Xie R; Jonason JH; Tan X; Hou W; Reynolds D; Hsu W; Harris SE; Puzas JE; Awad H; O'Keefe RJ; Boyce BF; Chen D
J Cell Sci; 2009 Oct; 122(Pt 19):3566-78. PubMed ID: 19737815
[TBL] [Abstract][Full Text] [Related]
14. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone.
Sakamoto A; Chen M; Nakamura T; Xie T; Karsenty G; Weinstein LS
J Biol Chem; 2005 Jun; 280(22):21369-75. PubMed ID: 15797856
[TBL] [Abstract][Full Text] [Related]
17. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.
Shi K; Parekh VI; Roy S; Desai SS; Agarwal SK
Endocr Relat Cancer; 2013 Feb; 20(1):111-22. PubMed ID: 23419452
[TBL] [Abstract][Full Text] [Related]
18. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.
Zhu W; Liang G; Huang Z; Doty SB; Boskey AL
J Biol Chem; 2011 Jul; 286(30):26794-805. PubMed ID: 21636574
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
[TBL] [Abstract][Full Text] [Related]
20. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
